Go to Page # Page of 74

TTYBiopharm Company Overview

 Ralf Linker, Fred Lublin, Frederike Barkhof, Cai Qingbiao
  16th-Jun-2017
Description: The only PIC/S GMP certified manufacture sites for high potency oncology, 2008/2013/2016 EMA, 2010/2014 Japan, 2013/2016 US FDA, 2013 Brazil,Australia. High standard Validation of. Equipment qualification/ Laboratory instruments qualification/ HVAC system/ Water system/ Compressed air system/ Nitrogen system/ Cleaning/ Analytical method/ Process/ Computer/ Logistic.
Views: 1022
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: TTY Biopharm
 ‐ More of their Presentations
LithoVision 2018
Contents:
May, 2017

2016- NTD 3.80 Billion, USD 117 Million
508
(March, 2017)










TTY Biopharm is a global leader in Super-Generic Drugs and
novel specialty/ bio-drug development with strong growth
potentials (targeting for 20% sales CAGR in 2014-19).
TTY is Taiwan’s largest biotechnology conglomerate with the
most completed biotechnology products pi ... See more

Recent Presentations

...
19 February, 2018

Clinical Use Of Stem Cells In Orthopaedics

Stem cell research arose from the need to explore new therapeutic possibilities for intractable and lethal diseases. Although musculoskeletal disorders are basically nonlethal, the

...
17 February, 2018
Arnold Evia
16 February, 2018